DuPont de Nemours financials
$130.12−0.66%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.82B | $1.68B | — | $3.07B | $1.75B | $1.61B | $3.09B | $2.86B | $3.17B | $2.93B | $2.90B | $3.06B |
| Gross profit | $639.0M | $602.0M | — | $1.20B | $606.0M | $543.0M | $1.13B | $1.12B | $1.18B | $1.01B | $1.03B | $1.10B |
| Gross margin | 35.1% | 35.8% | — | 38.9% | 34.6% | 33.7% | 36.4% | 39.2% | 37.1% | 34.6% | 35.5% | 36.1% |
| Operating income | $256.0M | $186.0M | — | $388.0M | $162.0M | $95.0M | $342.0M | $432.0M | $459.0M | $313.0M | -$516.0M | $444.0M |
| Net income | $143.0M | $161.0M | — | -$123.0M | $59.0M | -$589.0M | -$118.0M | $455.0M | $178.0M | $189.0M | -$22.0M | $319.0M |
| Net margin | 7.9% | 9.6% | — | −4.0% | 3.4% | −36.5% | −3.8% | 15.9% | 5.6% | 6.4% | −0.8% | 10.4% |
| Diluted EPS | $1.05 | $1.17 | — | $-0.87 | $0.42 | $-4.20 | $-0.84 | $3.24 | $1.26 | $1.35 | $-0.15 | $2.10 |
| EBITDA | $414.0M | $387.0M | -$125.0M | $591.0M | $383.0M | $344.0M | $336.0M | $641.0M | $770.0M | $646.0M | $400.0M | $755.0M |
| Operating cash flow | $321.0M | $153.0M | $71.0M | $650.0M | $340.0M | $351.0M | $559.0M | $707.0M | $119.0M | $462.0M | $549.0M | $671.0M |
| Free cash flow | $245.0M | $51.0M | -$79.0M | $532.0M | $290.0M | $229.0M | $468.0M | $640.0M | $17.0M | $255.0M | $404.0M | $552.0M |
| Diluted shares | 136.8M | 137.6M | 232.3M | 140.0M | 139.9M | 140.0M | 137.9M | 139.8M | 139.8M | 141.4M | 141.9M | 151.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.74B | $710.0M | $715.0M | $1.96B | $1.84B | $1.76B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $3.13B | $3.17B | $3.19B | $8.90B | $7.17B | $7.17B |
| Total assets | $21.06B | $21.45B | $21.57B | $38.04B | $36.56B | $35.98B |
| Total liabilities | $7.18B | $7.21B | $7.47B | $14.70B | $13.04B | $12.71B |
| Shareholders' equity | $13.88B | $14.24B | $14.10B | $23.34B | $23.52B | $23.27B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology